为制备鼠疫耶尔森氏菌F1-V重组融合蛋白抗原,观察其免疫原性和免疫保护效果,通过疏水层析、阴离子交换层析、凝胶过滤层析纯化鼠疫F1-V重组融合蛋白抗原. 用氢氧化铝凝胶吸附制备试验性鼠疫F1-V重组融合蛋白抗原,皮下接种健康BALB/c小鼠, ELISA检测血清F1-V抗体效价、MTT法测定淋巴细胞增殖能力,进一步用400LD50鼠疫耶尔森氏菌141标准毒株皮下攻毒,观察动物的存活情况. 通过三步柱层析纯化获得的鼠疫F1-V重组融合蛋白抗原纯度达到90%以上. 氢氧化铝凝胶吸附的鼠疫F1-V重组融合蛋白抗原免疫BALB/c小鼠三次,血清抗F1-V抗体效价为1∶(51 200±800),对耶尔森氏菌141强毒株攻击的保护率是90%. 上述结果表明,制备的鼠疫F1-V重组融合蛋白抗原具有良好的免疫原性和免疫保护效果,为研制鼠疫F1-V重组融合蛋白疫苗奠定了基础.
F1-V recombinant fusion protein was purified to immunize mice and its immunogenicity and immuno-protection are detected. Different purification strategies were used to purify F1-V recombinant fusion protein. First hydrophobic chromatography, then anion exchange chromatography, and finally size exclusion chromatography. Aluminium hydroxide gel adsorbed F1-V fusion protein was intramuscularly injected into BALB/c mice. Anti-serum titer and protection ratio were detected. The purity of F1-V recombinant fusion protein was more than 90%. The anti-serum titer was high up to 1∶(51 200 ± 800). The protein antigen was capable of inducing an effective immuno-protection against subcutaneous challenge of 400 LD50 virulent Yersinia pestis with the survival rate of 90%. The F1-V recombinant fusion protein was able to protect against subcutaneous challenge of virulent Yersinia pestis, suggesting that the F1-V substance is well suited for developmentas the active ingredient of the next plague vaccine.
王 栋,黄顺军,邢 丽,郭习勤,韩 岳,罗德炎,李 敏,王希良.鼠疫F1-V重组融合蛋白抗原的制备及其免疫保护效果的研究[J].生物化学与生物物理进展,2006,33(3):287-291
复制生物化学与生物物理进展 ® 2024 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号